Ultragenyx Pharmaceutical Inc. Analytics - Traffic, Statistics and Competitor Tracking


Ultragenyx Pharmaceutical Inc. Website Screenshot

http://www.ultragenyx.com

Ultragenyx Pharmaceutical Inc. Company Intro

Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.

Industry

Healthcare

Ultragenyx Pharmaceutical Inc. Headquaters

60 Leveroni Court
Novato,94949
United States


Ultragenyx Pharmaceutical Inc. Share price

27 Jan 2021 02:28 GMT

$147.67

0.91 (0.62 %)


Ultragenyx Pharmaceutical Inc. Market cap

$9.26 B


WMC RANKING

2021

Ultragenyx Pharmaceutical Inc. # 51

Biotechnology

Latest Ultragenyx Pharmaceutical Inc. News

News 10 Jan 2021

Short Blade Swim Fins Market Growing Rapidly with Trends ...

6.2 Ultragenyx Pharmaceutical. 6.2.1 Ultragenyx Pharmaceutical Corporation Information. 6.2.2 Ultragenyx Pharmaceutical Description, Business Overview and ...

News 10 Jan 2021

Stevia Sugar Market to Witness Astonishing Growth with Key ...

6 Company Profiles and Key Figures in Stevia Sugar Business. 6.1 Kyowa Kirin ... 6.2.1 Ultragenyx Pharmaceutical Corporation Information. 6.2.2 Ultragenyx ...

News 10 Jan 2021

Industrial Electromagnetic Multi-Disc Clutch Market Growing ...

2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3). 2.6 Manufacturers ... 6.2.1 Ultragenyx Pharmaceutical Corporation Information. 6.2.2 Ultragenyx ...


WMC Market Score


WMC Market to Revenue Score


Ultragenyx Pharmaceutical Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Ultragenyx Pharmaceutical Inc. USD $121,851 $562,422 $-424,996 $92,600B 51
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $580,590B 1
Alexion Pharmaceuticals, Inc. USD $5,862,400 $2,588,400 $956,600 $353,780B 2
Vertex Pharmaceuticals Incorporated USD $5,991,128 $2,596,854 $2,690,691 $617,950B 3
ALK-Abello A/S USD $3,383,000 $1,831,000 $43,000 $271,640B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Ultragenyx Pharmaceutical Inc. Social Followers vs Top 4 Industry Competitors



Ultragenyx Pharmaceutical Inc. Post vs Top 4 Industry Competitors




Ultragenyx Pharmaceutical Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Ultragenyx Pharmaceutical Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Ultragenyx Pharmaceutical Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Ultragenyx Pharmaceutical Inc. 1.32 0 0 0 0 0 0.20
Regeneron Pharmaceuticals, Inc. 100 66.47 10.77 100 0 0 93.77
Alexion Pharmaceuticals, Inc. 63.42 16.60 100 60 0 0 93.49
Vertex Pharmaceuticals Incorporated 64.81 100 3.19 86 0 0 100
ALK-Abello A/S 36.60 0 0 0 0 0 0

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries